气压治疗联合依诺肝素钠在剖宫产术后下肢深静脉血栓形成预防中的应用价值

doi:10.3969/j.issn.1671-7171.2026.04.026

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1171 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the application value of pneumatic therapy combined with enoxaparin sodium in preventing lower extremity deep vein thrombosis (DVT) after cesarean section. 【Methods】 A total of 130 puerperae who underwent cesarean section in our hospital from May 2023 to May 2024 were enrolled and randomly divided into an observation group and a control group using a random number table, with 65 cases in each group. The control group received pneumatic therapy after cesarean section, while the observation group received pneumatic therapy combined with enoxaparin sodium after cesarean section. The incidence of lower extremity DVT, adverse reactions, hemorheological indexes, coagulation function indexes, inflammatory factor levels, and vascular endothelial function indexes of the two groups were compared after cesarean section. 【Results】 The incidence of lower extremity DVT in the observation group was 1.54% (1/65), which was significantly lower than 10.77% (7/65) in the control group, with a statistically significant difference (χ²=4.795, P=0.028). After treatment, the plasma viscosity, whole blood low-shear viscosity, and whole blood high-shear viscosity in the observation group were lower than those in the control group; the fibrinogen level was lower than that in the control group; the activated partial thromboplastin time, thrombin time, and prothrombin time were shorter than those in the control group, and all differences were statistically significant (P<0.05). After treatment, the levels of intercellular adhesion molecule 1, platelet-activating factor, matrix metalloproteinase 9, endothelin-1, and vascular endothelial growth factor in the observation group were lower than those in the control group (P<0.05). 【Conclusion】 Pneumatic therapy combined with enoxaparin sodium can prevent the occurrence of postoperative lower extremity DVT by improving the postoperative hypercoagulable state of puerperae after cesarean section, reducing the levels of inflammatory factors, and reducing vascular endothelial damage.

Key words： Cesarean Section Enoxaparin Venous Thrombosis Lower Extremity

Received: 14 May 2025

PACS:

R719.8

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU Xia
	SONG Xiaoqing
	LIU Shuzhi

Cite this article:

XU Xia,SONG Xiaoqing,LIU Shuzhi. Application Value of Pneumatic Therapy Combined with Enoxaparin Sodium in Preventing Lower Extremity Deep Vein Thrombosis after Cesarean Section[J]. JOURNAL OF CLINICAL RESEARCH, 2026, 43(4): 621-624.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2026.04.026 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2026/V43/I4/621

[1] RUDNIN S, KAMINSKY J, GHOSH R, et al. Distribution of lower extremity deep vein thrombosis and implications for limited compression ultrasound examinations[J].J Emerg Med,2022 ,63(3):348-354.
[2] 李荣会, 赖亚辉, 黄海燕. 基于发生风险列线图模型的护理干预对剖宫产产妇下肢深静脉血栓的预防效果[J].中国医药导报, 2022,19(18):166-169.
[3] 张丽娜, 王玉华, 罗穗豫, 等. 分级心理干预联合气压泵气压治疗对宫颈癌术后患者下肢深静脉血栓形成的预防效果[J].癌症进展, 2023,21(6):652-655.
[4] 刘梁彦, 王军, 金华, 等. 依诺肝素钠联合阿司匹林治疗对高危产妇剖宫产术后血脂、凝血功能及DVT的影响[J].空军航空医学, 2022,39(5):252-254.
[5] 中华医学会妇产科学分会产科学组. 妊娠期及产褥期静脉血栓栓塞症预防和诊治专家共识[J].中华妇产科杂志,2021,56(4):236-243.
[6] 王园. 中药穴位贴敷预防剖宫产术后下肢深静脉血栓的临床观察[J].中国中医药科技, 2021,28(2):278-280.
[7] 杨光, 王会芝, 朱培静, 等. 气压治疗仪对剖宫产后下肢静脉血流动力学及深静脉血栓形成发生率的影响研究[J].中国医学装备, 2020,17(3):104-107.
[8] 梁秋金, 温志玲, 覃慧花, 等.通络祛风散沐足联合气压治疗预防腰椎内固定术后下肢深静脉血栓的临床观察[J].广州中医药大学学报, 2020,37(4):617-621.
[9] 杨晓娜, 赵良虎, 黄金, 等. 依诺肝素钠与磺达肝癸钠预防膝关节置换术后深静脉血栓的对比研究[J].中国医院用药评价与分析, 2021,21(10):1176-1179.
[10] KONDREDDY V, KESHAVA S, DAS K, et al. The Gab2-MALT1 axis regulates thromboinflammation and deep vein thrombosis[J].Blood,2022,140(13):1549-1564.
[11] RANERO S, SILVEIRA G, TRIAS N, et al. Endothelium-biomarkers for postthrombotic syndrome: a case-control study[J].Blood Coagul Fibrinolysis,2023 ,34(3):144-151.
[12] YANG F, CHEN D X, LIU Y, et al. Overexpression of MiR-181c-5p attenuates human umbilical vascular endothelial cell injury in deep vein thrombosis by targeting FOS[J].Int Heart J,2023,64(4):759-767.
[13] LI Y, GE J P, MA K, et al. The combination of EGCG with warfarin reduces deep vein thrombosis in rabbits through modulating HIF-1α and VEGF via the PI3K/AKT and ERK1/2 signaling pathways[J].Chin J Nat Med,2022,20(9):679-690.
[14] 高丽欣,李烁,王丛. 依诺肝素联合阿司匹林对既往妊娠高血压疾病和胎儿生长受限患者的应用价值[J].中国性科学,2020,29(1):52-56.